NEOGENOMICS INC Selling and Marketing Expense in USD from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Neogenomics Inc quarterly/annual Selling and Marketing Expense history and growth rate from Q2 2010 to Q3 2025.
  • Neogenomics Inc Selling and Marketing Expense for the quarter ending September 30, 2025 was $21.8M, a 6.81% increase year-over-year.
  • Neogenomics Inc Selling and Marketing Expense for the twelve months ending September 30, 2025 was $90.9M, a 13.1% increase year-over-year.
  • Neogenomics Inc annual Selling and Marketing Expense for 2024 was $84.7M, a 19.5% increase from 2023.
  • Neogenomics Inc annual Selling and Marketing Expense for 2023 was $70.8M, a 5.23% increase from 2022.
  • Neogenomics Inc annual Selling and Marketing Expense for 2022 was $67.3M, a 7.55% increase from 2021.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)

NEOGENOMICS INC Quarterly Selling and Marketing Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $90.9M $21.8M +$1.39M +6.81% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-28
Q2 2025 $89.5M $24.1M +$2.4M +11.1% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-29
Q1 2025 $87.1M $22.7M +$2.46M +12.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-29
Q4 2024 $84.7M $22.3M +$4.27M +23.6% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-18
Q3 2024 $80.4M $20.4M +$2.81M +15.9% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-28
Q2 2024 $77.6M $21.7M +$2.78M +14.7% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-29
Q1 2024 $74.8M $20.2M +$3.96M +24.4% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-29
Q4 2023 $70.8M $18.1M +$930K +5.43% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-18
Q3 2023 $69.9M $17.6M +$801K +4.77% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $69.1M $18.9M +$1.83M +10.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 $67.3M $16.3M -$40K -0.25% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $67.3M $17.1M +$1.23M +7.7% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-18
Q3 2022 $66.1M $16.8M +$1.11M +7.04% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $65M $17.1M -$153K -0.89% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $65.1M $16.3M +$2.55M +18.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $62.6M $15.9M +$2.81M +21.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $59.8M $15.7M +$4.4M +38.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $55.4M $17.2M +$7.03M +68.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $48.4M $13.7M +$491K +3.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $47.9M $13.1M +$803K +6.53% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 $47.1M $11.3M -$204K -1.77% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $47.3M $10.2M -$2.13M -17.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $49.4M $13.3M +$2.04M +18.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $47.4M $12.3M +$4.26M +52.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $43.1M $11.5M +$4.61M +66.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $38.5M $12.3M +$4.64M +60.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $33.8M $11.2M +$4.44M +65.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $29.4M $8.05M +$2.19M +37.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $27.2M $6.9M +$537K +8.44% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $26.7M $7.68M +$1.55M +25.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $25.1M $6.78M +$1.13M +20% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $24M $5.86M +$33K +0.57% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 $24M $6.36M +$405K +6.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $23.6M $6.13M -$195K -3.08% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $23.8M $5.65M -$152K -2.62% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $23.9M $5.83M +$2.83M +94.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $21.1M $5.96M +$3.21M +117% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $17.9M $6.33M +$3.42M +118% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $14.4M $5.8M +$2.89M +99% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $11.6M $2.99M -$232K -7.19% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-13
Q3 2015 $11.8M $2.75M -$235K -7.88% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $12M $2.91M -$251K -7.95% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $12.3M $2.91M +$281K +10.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $12M $3.23M +$738K +29.7% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-14
Q3 2014 $11.3M $2.98M +$647K +27.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $10.6M $3.16M +$1.19M +60.1% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-31
Q1 2014 $9.43M $2.63M +$702K +36.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $8.73M $2.49M +$795K +47% Oct 1, 2013 Dec 31, 2013 10-K 2016-04-18
Q3 2013 $7.93M $2.34M +$497K +27% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 $7.43M $1.97M +$38K +1.97% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-29
Q1 2013 $7.4M $1.93M -$105K -5.16% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $7.5M $1.69M -$109K -6.05% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-03
Q3 2012 $7.61M $1.84M +$114K +6.61% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-30
Q2 2012 $7.5M $1.93M +$250K +14.8% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q1 2012 $7.25M $2.04M +$283K +16.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q4 2011 $6.96M $1.8M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-24
Q3 2011 $1.73M -$258K -13% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-05
Q2 2011 $1.68M -$259K -13.3% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-15
Q1 2011 $1.75M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q3 2010 $1.98M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-25
Q2 2010 $1.94M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-01

NEOGENOMICS INC Annual Selling and Marketing Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $84.7M +$13.8M +19.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-18
2023 $70.8M +$3.52M +5.23% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-18
2022 $67.3M +$4.73M +7.55% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-18
2021 $62.6M +$14.7M +30.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $47.9M +$512K +1.08% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-24
2019 $47.4M +$17.9M +61% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $29.4M +$5.4M +22.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $24M +$91K +0.38% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $23.9M +$12.3M +107% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 $11.6M -$437K -3.64% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-13
2014 $12M +$3.27M +37.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-14
2013 $8.73M +$1.23M +16.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-04-18
2012 $7.5M +$538K +7.73% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-03
2011 $6.96M -$516K -6.9% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-24
2010 $7.48M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.